These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21744107)

  • 21. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmarketing experience with topiramate and cognition.
    Tatum WO; French JA; Faught E; Morris GL; Liporace J; Kanner A; Goff SL; Winters L; Fix A;
    Epilepsia; 2001 Sep; 42(9):1134-40. PubMed ID: 11580760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible hemiparesis associated with the use of topiramate.
    Patel H; Asconapé JJ; Garg BP
    Seizure; 2002 Oct; 11(7):460-3. PubMed ID: 12237075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate and temporal lobe epilepsy: an open-label study.
    Labate A; Siniscalchi A; Mumoli L; Aguglia U; Quattrone A; Gambardella A
    Epileptic Disord; 2012 Jun; 14(2):163-6. PubMed ID: 22576069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate and psychiatric adverse events in patients with epilepsy.
    Mula M; Trimble MR; Lhatoo SD; Sander JW
    Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of topiramate and its clinical value in epilepsy.
    Bai YF; Zeng C; Jia M; Xiao B
    Seizure; 2022 May; 98():51-56. PubMed ID: 35421622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy.
    Witt JA; Elger CE; Helmstaedter C
    Eur J Neurol; 2013 Jan; 20(1):130-7. PubMed ID: 22827489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypohidrosis related to the administration of topiramate to children.
    Arcas J; Ferrer T; Roche MC; Martínez-Bermejo A; López-Martín V
    Epilepsia; 2001 Oct; 42(10):1363-5. PubMed ID: 11737174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive impairments due to add-on therapy with topiramate].
    Huppertz HJ; Quiske A; Schulze-Bonhage A
    Nervenarzt; 2001 Apr; 72(4):275-80. PubMed ID: 11320862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered cerebral activity associated with topiramate and its withdrawal in patients with epilepsy with language impairment: An fMRI study using the verb generation task.
    Tang Y; Xia W; Yu X; Zhou B; Wu X; Lui S; Luo C; Huang X; Ouyang L; Chen Q; Gong Q; Zhou D
    Epilepsy Behav; 2016 Jun; 59():98-104. PubMed ID: 27123530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic frontal lobe epilepsy in children].
    Boldyreva SR; Ermakov AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):58-65. PubMed ID: 20559276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using topiramate in patients with epilepsy: practical aspects.
    Sander JW
    Can J Neurol Sci; 1998 Aug; 25(3):S16-8. PubMed ID: 9706736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
    Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
    Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
    Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
    Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate and metabolic acidosis in infants and toddlers.
    Philippi H; Boor R; Reitter B
    Epilepsia; 2002 Jul; 43(7):744-7. PubMed ID: 12102678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
    Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
    Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.